Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?

Movement Disorders Clinical Practice

Volumn 4, Issue 4, 2017, Pages 582-585

  Rodrigues, Filipe B ^a,b,c   Duarte, Gonçalo S ^b,c   Costa, João ^b,c   Ferreira, Joaquim J ^b,c   Wild, Edward J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

deutetrabenazine; Huntington's disease; indirect comparison; meta analysis; tetrabenazine

Indexed keywords

DEUTETRABENAZINE; PLACEBO; TETRABENAZINE;

ARTICLE; COUSIN; DEPRESSION; DEPRESSION SCALE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; EPWORTH SLEEPINESS SCALE; FALLING; FATIGUE; HUMAN; HUNTINGTON CHOREA; INSOMNIA; META ANALYSIS; MOTOR DYSFUNCTION; MOTOR SCORE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SOMNOLENCE; TWINS; UNIFIED HUNTINGTON DISEASE RATING SCALE;

EID: 85033670220     PISSN: None     EISSN: 23301619     Source Type: Journal    
DOI: 10.1002/mdc3.12483     Document Type: Article

References (10)

1. Bates GP, Dorsey R, Gusella JF, et al. Huntington disease [serial online]. Nat Rev Dis Primers 2015;1:15005.
2. Kaur N, Kumar P, Jamwal S, Deshmukh R, Gauttam V. Tetrabenazine: spotlight on drug review. Ann Neurosci 2016;23:176–185.
3. Jankovic J. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother 2016;17:2461–2470.
4. Huntington Study Group, Frank S, Testa CM, et al. Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial. JAMA 2016;316:40–50.
5. Reilmann R. Deutetrabenazine-not a revolution but welcome evolution for treating chorea in Huntington disease. JAMA Neurol 2016;73:1404–1406.
6. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015;162:777–784.
7. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997;50:683–691.
8. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011;64:380–382.
9. Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 2006;66:366–372.
10. Mills EJ, Ghement I, O'Regan C, Thorlund K. Estimating the power of indirect comparisons: a simulation study [serial online]. PLoS One 2011;6:e16237.